Investigator Site 8 - US0010003 — Chicago, Illinois

Investigator Site 8 - US0010003 is a clinical research site located in Chicago, Illinois, United States 60611.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Investigator Site 8 - US0010003 has participated in 1 clinical trials.

Therapeutic areas: Generalized Myasthenia Gravis, MG - Myasthenia Gravis, gMG.

Sponsors: argenx.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigator Site 8 - US0010003?

Investigator Site 8 - US0010003 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigator Site 8 - US0010003 conducted?

Investigator Site 8 - US0010003 has 1 clinical trials on record. Their work covers Generalized Myasthenia Gravis, MG - Myasthenia Gravis, gMG.

Is Investigator Site 8 - US0010003 accredited by Crixeo Health?

Investigator Site 8 - US0010003 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigator Site 8 - US0010003?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.